Chloroquine |
Poly (lactic) acid |
Herpes simplex virus-1 |
Enhanced release and targeted transportation |
[57] |
Zidovudine |
Cellulose poly (ethylene glycol) |
Human immunodeficiency virus |
Enhanced release, enhanced encapsulation and targeted transportation |
[58] |
Zidovudine |
Poly (vinyl pyrrolidone/sialic acid, poly (ethylene glycol) |
Human immunodeficiency virus |
Enhanced cellular internalization |
[59] |
Latency-reversing molecules |
Polylactide-co-glycolide |
Human immunodeficiency virus |
Reduced toxicity |
[60] |
Glutathione |
Silver sulfide |
Porcine epidemic diarrhea virus |
Decreased viral titer |
[61] |
Oseltamivir |
Zinc oxide |
Influenza A virus |
Enhanced the viability of infected cells |
[62] |
Zanamivir |
Selenium |
Influenza A virus |
Enhanced the viability of infected cells |
[63] |